Cancer charities have condemned a decision not to licence a drug being trialled in our region which extends the life of women suffering the advanced stages of breast cancer.
The National Institute for Clinical Excellence - or NICE - says the drug "Perjeeta" isn't cost effective.
Perjeeta is currently being tested on women through the Christie Hospital in Manchester - but it isn't routinely available on the NHS.
Cancer charities and women taking the drug want NICE to reconsider .
Ashley Derricott reports.
More top news
The brother-in-law of a British hostage being held by Islamic State militants in Syria, says he is scared by US airstrikes in the country.
A survivor of the Hillsborough disaster had described how two fans pulled him out of a pile of bodies after a crush barrier collapsed.
A Liverpool fan has spoken of the "anxiety, stress and panic" in the stands on the day of the disaster.